Quality to the Nth Degree

 


Company

Contact us

Services

Nth News

Nth on Twitter

Client list

Servers

eBrochure

Capabilities

Pharma News >900 companies

News by company

Top Pharma News

Twitter Pharma

Pharma Blogs

FDA News

PharmAsia

SAS Blogs

Services

Biostat

CDISC SDTM

Validation

PK/PD

Contractors

Key Staff

President

Corp. Development

Links

DIA

CDISC

AmStat

ClinicalTrials.gov

PhilaSUG

Reference

ICH

E1

E2A

E2B

E2BQ&A

E2C

E2D

E2E

E3

E4

E5

E5Q&A

E6

E7

E8

E9

E10

E11

E12

E14

E15

eCTD  
CDISC

Roadmap

SDTM V3.1.1 IG

SDTM V1.1

SDTM V3.1.2 draft

SDTM V1.2 draft

Define.xml

Annotated CRF

Trial Design Part 2

WebSDM

Janus SDTM Valid

ISO Country Codes

Susan Kenney SDTM strategies

Susan Kenney CDISC for Safety Data

ADaM V2.0

Pilot

FDA

Drug approval docs

Guidance page

Race/etnicity guidance

QTc Guidance

SDTM proposed rule

eCTD

Critical path

Hy's Law

ADR Guidance

Validation

21CRFPart11.com

21 CFR Part 11

Part 11 guidance

Part 11 Withdrawal

Computerized Systems Guidance

Software Validation Glossary

FDA Computer System Validation Website

Software Validation Guidance

SAS

Documentation

BI

RTF Specification

 

Nth Analytics is a Clinical Biometrics Services consulting firm that offers a full suite of high-quality, cost-efficient Biometrics services to the pharmaceutical industry. We tackle large and small projects involving all aspects of managing, summarizing, reporting and analyzing clinical data.

We provide top-notch SAS programming, statistical analysis and pharmacokinetics services for clinical trials. Our experience includes most therapeutic areas, as well as reporting and analysis for vaccine trials. Our clients include major pharmaceutical companies and as well as biotechnology companies and Contract Research Organizations (CROs).

Founded in 1989 by Mike Todd, a pharmaceutical statistician with 25 years experience,  Nth Analytics handles mission-critical assignments with relentless dedication to accuracy and quality, a sensitive grasp of nuance and a keen appreciation for detail.

Success is expected. Failure has consequences.

Good outcomes come from good technology, good people, good project management, and good QC. Solid procedures and experienced people make the difference. We have no tolerance for poor work.

 

Latest Pharma Industry News

Nth Latest

Nth Analytics was accepted into the SAS Consulting Alliance program! We will be helping SAS implement the advanced Life Sciences software like SAS Clinical Data Integration, SAS Drug Development, and SAS Patient Safety! Stay tuned ...

Mike Todd presented Using Google to Solve SAS Programming Problems at the SAPA Clinical Programming Workshop. Oct 10, 2009 at Princeton University.  This was really a great conference.  Listen to the presentation here (mp3)

Nth Analytics was a SAS Featured Customer for our quality improvements with SAS Enterprise Guide. With this product, we streamlined the coding process and reduced errors, shrinking the time it takes to complete projects. Read the article.

Conference Presentations

Michael Todd, President of Nth Analytics has been an invited speaker at the last 3 CDISC Interchange Conferences.  These presentations cover strategies for converting legacy data to SDTM. Other presentations cover reporting systems based on SDTM, vaccine reporting requirements, and economics of contracting.

SDTM Mapping: Current Technology and Expert Systems, Michael Todd and Thomas Jablonski, DIA Annual Meeting, San Diego, CA, June 24 2009 (no audio)

Transitioning to SAS® Enterprise Guide®, Michael Todd, NESUG conference, Pittsburg, PA, September 15, 2008 listen to the presentation (mp3) read publication click here

CDISC SDTM  Implementation Process, Michael Todd, DIA Annual Meeting, Boston, MA, June 25, 2008 listen to the presentation (mp3)

Metadata-Driven Technology for Implementing CDISC SDTM, Michael Todd, DIA Annual Meeting, Boston, MA, June 23, 2008 listen to the presentation (mp3)

Using SAS® Enterprise Guide® to Create Standalone Programs, Michael Todd, PhilaSUG 2008 Winter Meeting, Malvern PA, March 13, 2008 listen to the presentation (mp3) read publication click here

Standard SDTM Methodology with Legacy Data, Michael Todd and Barbara Costantini, CDISC Legacy Data Workshop, Bethesda, MD, October 4, 2007 listen to the presentation (mp3)

Legacy to SDTM Conversion Workshop: Tools and Techniques, Michael Todd, CDISC Legacy Data Workshop, Montreaux, Switzerland, April 27, 2007

Legacy to SDTM Conversion Workshop: Tools and Techniques, Michael Todd, CDISC Legacy Data Workshop, Bethesda, MD, September 29, 2006

CDISC SDTM & Standard Reporting-One System, Michael Todd and Ram Radhakrishnan (Merck), CDISC Interchange Conference, Bethesda, MD, September 28, 2006

Tracking the Progress made by CDISC in Implementing New Standards, Michael Todd, Clinical Trial Data Integration, Harmonizing eClinical Systems, Processes, and People, Philadelphia, PA, January 24, 2006

Economics of Contracting, Michael Todd, Statistics Career Day, Temple University, Philadelphia, PA, December 17, 2005

Vaccine Reporting Requirements, Michael Todd, Merck Clinical Trials - Best Practices Workshop, Princeton, NJ, May 5, 1998

 

 

 

What We Do

Biostatistics

Our Masters and Ph.D. statisticians have substantial pharmaceutical experience in many clinical areas including vaccines, oncology,  endocrinology and CNS.

In the pharmaceutical industry, statistical analysis requires extreme attention to detail.  We can work with your most-demanding in-house statisticians to provide the accurate results you expect using standard processes employed within the pharmaceutical industry.

We provide the following services: Randomization, Data Safety Monitoring Board (DSMB) analyses, analysis plans, statistical programming specifications (e.g., table mockups), analysis datasets (ADaM), validation, statistical reports, and publication support.

SDTM Conversions

Get the details right!

Nth Analytics was among the first companies to qualify as a CDISC Registered Solutions Provider. One of only 21 such companies in the world, Nth Analytics was certified by the CDISC Technical Coordinating Committee to have, among other specialized criteria, an expertise in CDISC models. Approved CDISC Solutions Providers are qualified consultants, system integrators, and subject matter experts believed by CDISC to have sufficient knowledge and experience implementing the various CDISC standards.

We have done many SDTM conversions, from both current and legacy data, in vaccines, oncology, CNS, and other therapeutic areas. With over 40 years combined experience in data management, statistics, and programming, we identify cost-saving commonalities among your studies while still addressing all the nuances of each individual study.

 

Validation

We offer validation services in several areas. We are extremely detail-oriented and do a thorough job every time.

Tables, Listings, and Figures

Quality control (QC) review of the tables, listings and figures (TLFs) from the study data will help insure the accuracy and integrity of the data used in reporting the results of the study. A complete, extensive review takes place on the draft output, prior to sending the output to the client. Subsequent rounds of QC on final output may be less extensive, but must still be adequate to determine that the output is accurate.

SDTM

Our validation goes beyond what simple double programming can do. It includes review of the annotated CRF and mapping specifications for accuracy, full documentation of source data intentionally not mapped to SDTM, and detailed review of each SDTM file on the subject level.

We have developed a series of checks that validate compliance to SDTM standards. These are based on the 105 published checks used by the Lincoln Technology WebSDM product. These are the same checks used by the FDA upon receipt of your SDTM files. Passing these checks no ensures that you will have one less problem during your submission process.  

SDLC

We are very familiar with pharmaceutical SDLC methodology for system design and validation. We have done extensive SDLC projects for two large pharmaceutical companies under their stringent SOPs: our work passed their strict internal audits! Deliverables included:

Functional requirements specification (FRS)

System design

Entity-module matrix

Unit, integration, and system test plans and specifications

UAT plan and evaluation of UAT results

User manuals.

PK/PD Analyses

Pharmacokinetic (PK) and pharmacodynamic (PD) analyses in clinical drug development are critical steps in the drug approval process. We can provide these services through our partner Pharmax Research in Somerset, NJ. Pharmax's mission is to provide clinical research and development solution for pharmaceutical and biotechnology companies.

Pharmax's scientists have specific expertise in the application of PK and PD principles to clinical drug development, including population PK/PD modeling.

Sam Liao Ph.D. is the principal PK scientist for Pharmax Research. Sam's extensive experience in pharmaceutical R&D includes over 20 years in Clinical Pharmacokinetics and over 10 years experience in NONMEM population PK/PD modeling, as well as five years experience in Pharsight Trial Simulator™ for clinical trial simulation. Read more about Pharmax Research.

 

Contractors

We provide experienced SAS programmers and statisticians on short notice at very competitive rates. All of them are fully screened, including reference checks.  We interview each candidate to determine not just their technical skills, but how they will do in your particular situation. With our long pharmaceutical experience, we can screen the candidates very effectively. The key criteria we look for are:

Technical ability

Professionalism

Ability to handle pressure and meet deadlines

Validation/accuracy

Contractors: looking for opportunities? click here

 

Pharma News [Yahoo][Press Releases]

Yahoo

Major Pharma

Biotech

Small Pharma

Drug Delivery

Press Releases

PR Newswire

BusinessWire